scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1104022467 |
P356 | DOI | 10.1186/S12977-018-0419-0 |
P8608 | Fatcat ID | release_i42d5gxlezaexn3xejtnna5hqa |
P932 | PMC publication ID | 5956581 |
P698 | PubMed publication ID | 29769087 |
P50 | author | Sue VandeWoude | Q84943400 |
Carsten Münk | Q87799380 | ||
Martin Löchelt | Q114073589 | ||
Jörg Zielonka | Q115624664 | ||
P2093 | author name string | Xin Zheng | |
Ryan Troyer | |||
Guochao Wei | |||
Esther Musselman | |||
Dragana Slavkovic Lukic | |||
Ann-Mareen Franke | |||
Carmen Ledesma-Feliciano | |||
Daniel Maeda | |||
Sarah Hagen | |||
P2860 | cites work | AID and APOBECs span the gap between innate and adaptive immunity | Q21131084 |
An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs | Q22066003 | ||
Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors | Q24537623 | ||
Prototype foamy virus Bet impairs the dimerization and cytosolic solubility of human APOBEC3G | Q24629953 | ||
Frequent simian foamy virus infection in persons occupationally exposed to nonhuman primates | Q24633882 | ||
Evolution of foamy viruses: the most ancient of all retroviruses | Q26852372 | ||
Non-simian foamy viruses: molecular virology, tropism and prevalence and zoonotic/interspecies transmission | Q28673358 | ||
Intrinsic antiviral immunity | Q28709929 | ||
Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats. | Q30359813 | ||
Intravenous injection of a foamy virus vector to correct canine SCID-X1. | Q30409845 | ||
Vaccination with vif-deleted feline immunodeficiency virus provirus, GM-CSF, and TNF-alpha plasmids preserves global CD4 T lymphocyte function after challenge with FIV. | Q33575384 | ||
Foamy viruses are unconventional retroviruses | Q33652656 | ||
Foamy and lentiviral vectors transduce canine long-term repopulating cells at similar efficiency | Q33688423 | ||
Targeted Enrichment for Pathogen Detection and Characterization in Three Felid Species | Q33721505 | ||
Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors | Q42589642 | ||
Development of genetic vaccines for pathogenic genes: construction of attenuated vif DNA immunization cassettes. | Q42665583 | ||
Antibodies against Gag are diagnostic markers for feline foamy virus infections while Env and Bet reactivity is undetectable in a substantial fraction of infected cats | Q43219396 | ||
Serological detection systems for identification of cows shedding bovine foamy virus via milk | Q43222395 | ||
A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology | Q43625138 | ||
Antigenic Domains of the HIV-1vifProtein as Recognized by Human Sera and Murine Monoclonal Antibodies | Q43641567 | ||
Is feline foamy virus really apathogenic? | Q44694475 | ||
Detection and prevalence of serotypes of feline syncytial spumaviruses | Q44736573 | ||
Construction and functional characterization of feline foamy virus-based retroviral vectors | Q45146861 | ||
Clinical findings and survival in cats naturally infected with feline immunodeficiency virus | Q45350920 | ||
Kinetics and characteristics of replication-competent revertants derived from self-inactivating foamy virus vectors | Q45674657 | ||
Demonstration of feline foamy virus in experimentally infected cats by immunohistochemistry | Q45708499 | ||
Improved foamy virus vectors with minimal viral sequences | Q45730940 | ||
The bet gene of feline foamy virus is required for virus replication | Q45735832 | ||
Construction of infectious feline foamy virus genomes: cat antisera do not cross-neutralize feline foamy virus chimera with serotype-specific Env sequences | Q45745405 | ||
Detection and molecular characterisation of feline foamy virus serotypes in naturally infected cats | Q45754265 | ||
In vivo functions of the auxiliary genes and regulatory elements of feline immunodeficiency virus. | Q45755204 | ||
Isolation of a Virus from a Cat Sarcoma in an Established Canine Melanoma Cell Line | Q45809789 | ||
Syncytium-forming Agent isolated from Domestic Cats | Q59084738 | ||
Antibodies to recombinant HIV-1 vif, tat, and nef proteins in human sera | Q68505483 | ||
Feline immunodeficiency virus (FIV) as a model for study of lentivirus infections: parallels with HIV. | Q33786404 | ||
The antiretroviral activity of APOBEC3 is inhibited by the foamy virus accessory Bet protein | Q33841186 | ||
Epidemiology of feline foamy virus and feline immunodeficiency virus infections in domestic and feral cats: a seroepidemiological study. | Q33962452 | ||
Vif of feline immunodeficiency virus from domestic cats protects against APOBEC3 restriction factors from many felids | Q33966666 | ||
Remarkable lethal G-to-A mutations in vif-proficient HIV-1 provirus by individual APOBEC3 proteins in humanized mice | Q34120265 | ||
Foamy virus vector integration sites in normal human cells | Q34334976 | ||
Feline immunodeficiency virus infection | Q34453193 | ||
Regulation of adaptive immunity by the innate immune system | Q34659642 | ||
Epidemiologic and clinical aspects of feline immunodeficiency virus infection in cats from the continental United States and Canada and possible mode of transmission. | Q34666078 | ||
Application of chimeric feline foamy virus-based retroviral vectors for the induction of antiviral immunity in cats | Q35104790 | ||
Foamy combinatorial anti-HIV vectors with MGMTP140K potently inhibit HIV-1 and SHIV replication and mediate selection in vivo | Q35182775 | ||
Foamy virus transactivation and gene expression | Q35196124 | ||
Identification of a Cullin5-ElonginB-ElonginC E3 complex in degradation of feline immunodeficiency virus Vif-mediated feline APOBEC3 proteins | Q35531709 | ||
Vaccination of cats with attenuated feline immunodeficiency virus proviral DNA vaccine expressing gamma interferon | Q35634943 | ||
Replication-Competent Foamy Virus Vaccine Vectors as Novel Epitope Scaffolds for Immunotherapy | Q35784865 | ||
Foamy viruses--a world apart | Q35883042 | ||
Characterization of the genome of feline foamy virus and its proteins shows distinct features different from those of primate spumaviruses | Q35891703 | ||
HIV Restriction Factors and Mechanisms of Evasion | Q35902681 | ||
Clinical aspects of feline retroviruses: a review | Q36432701 | ||
Functions, structure, and read-through alternative splicing of feline APOBEC3 genes | Q36678568 | ||
APOBEC3G cytosine deamination hotspots are defined by both sequence context and single-stranded DNA secondary structure | Q36963205 | ||
Simian foamy virus in non-human primates and cross-species transmission to humans in Gabon: an emerging zoonotic disease in central Africa? | Q37030714 | ||
Determinants of FIV and HIV Vif sensitivity of feline APOBEC3 restriction factors. | Q37059673 | ||
Should accessory proteins be structural components of lentiviral vaccines? Lessons learned from the accessory ORF-A protein of FIV. | Q37096320 | ||
Species-specific inhibition of APOBEC3C by the prototype foamy virus protein bet | Q37104705 | ||
Foamy virus vectors for gene transfer | Q37594766 | ||
Restriction of feline retroviruses: lessons from cat APOBEC3 cytidine deaminases and TRIM5alpha proteins. | Q37629123 | ||
Feline foamy virus-based vectors: advantages of an authentic animal model | Q38121801 | ||
Identification of the feline foamy virus Bet domain essential for APOBEC3 counteraction | Q39121252 | ||
Molecular and functional interactions of cat APOBEC3 and feline foamy and immunodeficiency virus proteins: different ways to counteract host-encoded restriction | Q39408806 | ||
Prevalence of antibodies to recombinant virion infectivity factor in the sera of prospectively studied patients with HIV-1 infection | Q39440725 | ||
Productive replication of Vif-chimeric HIV-1 in feline cells | Q39704599 | ||
Construction and characterization of efficient, stable and safe replication-deficient foamy virus vectors | Q40187057 | ||
Characterization of the humoral immune response and virus replication in cats experimentally infected with feline foamy virus | Q40851382 | ||
The feline immunodeficiency virus vif gene is required for productive infection of feline peripheral blood mononuclear cells and monocyte-derived macrophages | Q40936391 | ||
Prevalence of anti-vif antibodies in HIV-1 infected individuals assessed using recombinant baculovirus expressed vif protein | Q41122204 | ||
Feline foamy virus adversely affects feline mesenchymal stem cell culture and expansion: implications for animal model development | Q41657843 | ||
P433 | issue | 1 | |
P921 | main subject | feline immunodeficiency virus | Q1129598 |
P304 | page(s) | 38 | |
P577 | publication date | 2018-05-16 | |
P1433 | published in | Retrovirology | Q15793508 |
P1476 | title | Replacement of feline foamy virus bet by feline immunodeficiency virus vif yields replicative virus with novel vaccine candidate potential. | |
P478 | volume | 15 |
Q89475126 | Diagnostic Uncertainty and the Epidemiology of Feline Foamy Virus in Pumas (Puma concolor) |
Q90597095 | FV Vectors as Alternative Gene Vehicles for Gene Transfer in HSCs |
Q92083317 | Feline Foamy Virus Infection: Characterization of Experimental Infection and Prevalence of Natural Infection in Domestic Cats with and without Chronic Kidney Disease |
Q64900311 | Feline Foamy Virus is Highly Prevalent in Free-Ranging Puma concolor from Colorado, Florida and Southern California. |
Q90291819 | Feline foamy virus seroprevalence and demographic risk factors in stray domestic cat populations in Colorado, Southern California and Florida, USA |
Q90342845 | First report on the prevalence and genetic relatedness of Feline Foamy Virus (FFV) from Turkish domestic cats |
Q64249992 | Twelfth International Foamy Virus Conference-Meeting Report |
Search more.